Jiangsu Kanion’s KYS202002A Greenlit for Clinical Study in Multiple Myeloma
China-based Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557) has announced receiving approval from the National...
Gaoling Medical Secures Funding for Infrared Thermotherapy Technology
Gaoling Medical, a Hangzhou-based developer of systemic infrared thermotherapy technology, has raised an undisclosed amount...
Yiling Pharmaceutical’s BIO-008 Accepted for Review by China’s NMPA
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced that its clinical trial filing for...
Sino Biopharmaceutical Secures Rights to Biosimilar of Amgen’s Xgeva in China
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its subsidiary CP Pharmaceutical Qingdao has...
CanSino Biologics to Issue GDRs on SWX Swiss Exchange to Boost Globalization
China-based CanSino Biologics (SHA: 688185, HKG: 6185) has announced plans to issue an undisclosed amount...
Luye Pharma Launches Named Patient Program for Lurbinectedin in Hong Kong
China-based Luye Pharma Group (HKG: 2186) has announced the launch of a Named Patient Program...
Innovent Biologics Doses First Patient in Phase III Study for Mazdutide
China-based Innovent Biologics, Inc. (HKG: 1801) has announced that the first patient has been dosed...
China Meheco Keyi Pharma’s Ganciclovir Loses VBP Bid After Inspection Failure
The national drug alliance procurement office has released a notification indicating that China Meheco Keyi...
NMPA Releases 63rd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 63rd batch of reference drugs for...
Cosunter’s COVID-19 Drug GST-HG171 Shows Superior Efficacy in Trial
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced positive results from an investigator-initiated...
Fosun Foundation Donates COVID-19 Therapy Azvudine to Rural China
The Fosun Foundation, Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), and Henan...
NMPA Approves Expanded Production for COVID-19 Symptom Treatments
The National Medical Products Administration (NMPA) has approved filings from multiple companies to expand manufacturing...
Roche’s Glofitamab and Dizal’s Sunvozertinib Enter Priority Review
The Center for Drug Evaluation (CDE) website indicates that Swiss giant Roche’s (SWX: ROG) glofitamab...
China Optimizes Medical Insurance Policies for COVID-19 Treatment
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center...
China Resources Biopharmaceutical Secures RMB 600 Million in Series B Funding
China Resources Biopharmaceutical Co., Ltd has announced the completion of a Series B financing round,...
Adagene’s ADG126 Shows Promise in Combination with Anti-PD-1 Therapy
China-based biotech Adagene Inc. (NASDAQ: ADAG), which also operates out of San Diego, California, has...
Pfizer CEO Denies Licensing Paxlovid to Chinese Generics Firms
Pfizer Inc. (NYSE: PFE) CEO Albert Bourla, speaking on the sidelines of the JPMorgan Healthcare...
Legend Biotech Receives Nasdaq Notice Regarding Listing Compliance
Legend Biotech Corporation (NASDAQ: LEGN) announced on January 6, 2023, that it received a notice...
Jiangxi Jemincare’s JMKX003142 Gets FDA Nod for Clinical Study
China-based Jiangxi Jemincare Group has announced receiving approval from the US Food and Drug Administration...